The Marked Chart Wire · Health
Hims & Hers
HIMS & Hers CEO outlines US manufacturing plans for new Peptides
The company's chief executive stated that TB-500 and BPC-157 will be produced and compounded domestically following the launch of the Peptides+ line.
Part of a series: Hims & Hers expands products and faces legal scrutiny
